PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.

[1]  U. Schibler,et al.  Poly(ADP-Ribose) Polymerase 1 Participates in the Phase Entrainment of Circadian Clocks to Feeding , 2010, Cell.

[2]  W. Kraus,et al.  The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. , 2010, Molecular cell.

[3]  B. Padanilam,et al.  PARP1 deficiency exacerbates diet-induced obesity in mice. , 2010, The Journal of endocrinology.

[4]  J. Auwerx,et al.  Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. , 2010, Cell metabolism.

[5]  Venkataraman Thanabal,et al.  SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1♦ , 2010, The Journal of Biological Chemistry.

[6]  A. Ashworth,et al.  Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. , 2009, The New England journal of medicine.

[7]  Brian C. Smith,et al.  A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. , 2009, Analytical biochemistry.

[8]  É. Szabó,et al.  Dual role of poly(ADP‐ribose) glycohydrolase in the regulation of cell death in oxidatively stressed A549 cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  J. Auwerx,et al.  The Role of Sirtuins in the Control of Metabolic Homeostasis , 2009, Annals of the New York Academy of Sciences.

[10]  S. Schinner.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity , 2009 .

[11]  J. Auwerx,et al.  Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. , 2008, Cell metabolism.

[12]  Shiwei Song,et al.  A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis , 2008, Proceedings of the National Academy of Sciences.

[13]  J. Auwerx,et al.  Peroxisome Proliferator-activated Receptor (PPAR)-2 Controls Adipocyte Differentiation and Adipose Tissue Function through the Regulation of the Activity of the Retinoid X Receptor/PPARγ Heterodimer* , 2007, Journal of Biological Chemistry.

[14]  Amy V. Lynch,et al.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.

[15]  J. Levine,et al.  The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet‐induced obesity , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  Dudley Lamming,et al.  Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival , 2007, Cell.

[17]  J. Auwerx,et al.  Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure , 2007, Proceedings of the National Academy of Sciences.

[18]  P. Puigserver,et al.  Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.

[19]  T. White,et al.  Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. , 2006, Biochemical and biophysical research communications.

[20]  P. Sassone-Corsi,et al.  Control of AIF-mediated Cell Death by the Functional Interplay of SIRT1 and PARP-1 in Response to DNA Damage , 2006, Cell cycle.

[21]  J. Auwerx,et al.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.

[22]  S. Imai,et al.  Poly(ADP-ribose) Polymerase-1-dependent Cardiac Myocyte Cell Death during Heart Failure Is Mediated by NAD+ Depletion and Reduced Sir2α Deacetylase Activity* , 2005, Journal of Biological Chemistry.

[23]  Michael M. Murphy,et al.  Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. , 2005, Cell metabolism.

[24]  Wilhelm Haas,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.

[25]  V. Schramm,et al.  Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition. , 2005, Molecular cell.

[26]  Phuong Chung,et al.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.

[27]  J. Denu,et al.  The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. , 2003, Molecular cell.

[28]  G. Dianov,et al.  Poly(ADP-ribose) polymerase in base excision repair: always engaged, but not essential for DNA damage processing. , 2003, Acta biochimica Polonica.

[29]  D. Sinclair,et al.  Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1* , 2002, The Journal of Biological Chemistry.

[30]  P. Chambers,et al.  Production, extraction, and purification of human poly(ADP-ribose) polymerase-1 (PARP-1) with high specific activity. , 2001, Protein expression and purification.

[31]  K. Murthy,et al.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.

[32]  P. Chambon,et al.  Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Adamietz.  Poly(ADP-ribose) synthase is the major endogenous nonhistone acceptor for poly(ADP-ribose) in alkylated rat hepatoma cells. , 1987, European journal of biochemistry.

[34]  D. Hinshaw,et al.  Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. , 1986, The Journal of clinical investigation.

[35]  S. J. Berger,et al.  Effects of nicotinamide on NAD and poly(ADP-ribose) metabolism in DNA-damaged human lymphocytes. , 1981, Journal of supramolecular structure and cellular biochemistry.

[36]  B. Durkacz,et al.  (ADP-ribose)n participates in DNA excision repair , 1980, Nature.